Acuta Capital Partners’s Sangamo Therapeutics SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-740,000
Closed -$755K 42
2024
Q4
$755K Buy
+740,000
New +$755K 0.76% 32
2018
Q2
Hold
0
56
2018
Q1
Hold
0
60
2017
Q3
Hold
0
56
2017
Q2
Hold
0
54